test bank for lehnes pharmacology for nursing care 9th edition by burchum

Chapter 03: Drug Regulation, Development, Names, an d Information Test Bank MULTIPLE CHOICE 1. A nurse educator is conducting a continuing educati on class on pharmacology. To evaluate the learning of the nurses in the class, the nurse educator asks, “Which drug name gives information about the drug’s pharmacologic classifi cation?” Which is the correct response? a. Amoxicillin b. Tylenol c. Cipro d. Motrin ANS: A Amoxicillin is the generic name, and the suffix “-c illin” indicates that it belongs to the penicillin class of antibiotics. Tylenol, Cipro, an d Motrin are all trade names without segments that indicate their pharmacologic class. PTS: 1 DIF: Cognitive Level: Comprehension REF: p. 18 TOP: Nursing Process: Diagnosis MSC: NCLEX Client Needs Category: Physiologic Integ rity: Pharmacologic and Parenteral Therapies 2. The FDA Amendments Act (FDAAA) was passed in 2007 t o address which aspect of drug safety? a. Allowing pharmaceutical companies to identify off-l abel uses of medications approved for other uses b. Evaluating drug safety information that emerges aft er a drug has been approved and is in use c. Expediting the approval process of the U.S. Food an d Drug Administration (FDA) so that needed drugs can get to market more quickly d. Requiring manufacturers to notify patients before r emoving a drug from the market ANS: B The FDAAA was passed to enable the Food and Drug Ad ministration to continue oversight of a drug after granting it approval so that changes i n labeling could be made as necessary and postmarketing risks could be tracked and identified . A provision of the FDA Modernization Act (FDAMA), passed in 1997, allows drug companies to promote their products for off-label uses as long as they promise to conduct studies to support their claims. Regulations to permit accelerated approval of drugs for life-threatening diseases were adopted in 1992 by the FDA. The requirement that drug companies notify patients 6 months before removing a drug from the market is a provision of the FDAMA. PTS: 1 DIF: Cognitive Level: Comprehension REF: pp. 14-15 TOP: Nursing Process: Evaluation MSC: NCLEX Client Needs Category: Physiologic Integ rity: Pharmacologic and Parenteral Therapies 3. A nursing student asks a nurse about pharmaceutical research and wants to know the purpose of randomization in drug trials. The nurse explains that randomization is used to do what? a. To ensure that differences in outcomes are the resu lt of treatment and not differences in subjects Test Bank for Lehnes Pharmacology for Nursing Care 9th Edition by Burchum
Full Download: https://downloadlink.org/p/test-bank-for-lehnes-pharmacology-for-nursing-care-9th-edition-by-burchum/
Full download all chapters instantly please go to Solutions Manual, Test Bank site: TestBankLive.com